DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists


INTRODUCTION No definitive data are available regarding the value of switching to an alternative TNF antagonist in rheumatoid arthritis patients who fail to respond to the first one. The aim of this study was to evaluate treatment response in a clinical setting based on HAQ improvement and EULAR response criteria in RA patients who were switched to a second… (More)
DOI: 10.1186/1471-2474-10-91

4 Figures and Tables


  • Presentations referencing similar topics